Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors-Reference-Cited by-同舟云学术

Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors

Published:2019-08-20 Issue:11 Volume:42 Page:2057-2064
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Lee Minyoung^ORCID,Sun Jiyu^ORCID,Han Minkyung,Cho Yongin,Lee Ji-Yeon,Nam Chung Mo^ORCID,Kang Eun Seok^ORCID

Funder

Yonsei University College of Medicine

Bio & Medical Technology Development Program

Publisher

American Diabetes Association

Subject

Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference59 articles.

1. Diabetes Mellitus as a Risk Factor for Pancreatic Cancer

2. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

3. Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes

4. Acute pancreatitis

5. A review of gliptins for 2014;Scheen;Expert Opin Pharmacother,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials;Clinical Therapeutics;2024-08

2. Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-05-27

3. A large-scale, observational study to investigate the current status of diabetes complication and their prevention in Japan: incidence/risk factors for malignancies during follow-up—JDCP study 11 (English version);Diabetology International;2024-05-23

4. The effect of incretin-based drugs on the riks of acute pancreatitis: a review;Journal of Diabetes & Metabolic Disorders;2024-05-05

5. Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity Score-Matching Analysis;Endocrinology and Metabolism;2023-08-31